Poland· PL-100540826
Adstiladrin
A nadofaragene firadenovec product containing nadofaragene firadenovec, registered in Poland by Ferring Pharmaceuticals A/S. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nadofaragene firadenovec is registered in 7 of 19 countries.
Countries holding a registration under ATC L01XL10 (nadofaragene firadenovec), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Nadofaragene firadenovec · ATC L01XL10
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Nadofaragene firadenovec
- Manufacturer
- Ferring Pharmaceuticals A/S
- Country
- Poland (PL)
- ATC code
- L01XL10
- ATC class
- Nadofaragene firadenovec
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nadofaragene firadenovec in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAdstiladrin 3 10*11 vp/mlFerring Pharmaceuticals
- CzechiaADSTILADRINFerring Pharmaceuticals A/S, Kastrup
- FinlandADSTILADRINFerring Pharmaceuticals A/S
- NetherlandsADSTILADRIN 3 × 1011 virusdeeltjes/ml intravesicale suspensieFerring Pharmaceuticals A/S
- SwedenADSTILADRIN 3 x 10E11 vp/ml Intravesikal suspensionFerring Pharmaceuticals A/S
- United StatesADSTILADRINFerring Pharmaceuticals Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Adstiladrin
- Liechtenstein · Adstiladrin
- Norway · Adstiladrin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/476bd111-076a-456b-bb69-ba6db9fd2770 GET /v1/drugs/476bd111-076a-456b-bb69-ba6db9fd2770?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina dopęcherzowa",
"source": "urpl",
"strength": "3 × 1011 cząstek wirusa/ml",
"packaging": null,
"substance": "Nadofaragene firadenovec 3 × 1011 cząstek wirusa/ml",
"common_name": "Nadofaragene firadenovec",
"pl_product_id": "100540826",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about nadofaragene firadenovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.